Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Journal of Biomedical Engineering ; (6): 597-599, 2008.
Article in Chinese | WPRIM | ID: wpr-291184

ABSTRACT

In this paper, we address the preparation of the EPC and HEPC sterically stabilized doxorubicin liposomes and report the data collected from further studies on pharmacokinetics in blood for choosing a better carrier in delivering the drugs. The pharmacokinetics of EPC and HEPC sterically stabilized liposomes (EPC-SSL, and HEPC-SSL) in Wistar rats were investigated by HPLC. The results showed that the mean residence time of HEPC-SSL in blood is 23.3 h, while that of EPC-SSL is 12.0 h. In conclusion, HEPC-SSL is a better carrier in delivering the drugs to the extravascular sites when compared with EPC-SSL.


Subject(s)
Animals , Rats , Antibiotics, Antineoplastic , Pharmacokinetics , Delayed-Action Preparations , Pharmacokinetics , Doxorubicin , Pharmacokinetics , Drug Carriers , Chemistry , Hydrogenation , Liposomes , Phosphatidylcholines , Chemistry , Pharmacology
2.
Journal of Biomedical Engineering ; (6): 1031-1035, 2005.
Article in Chinese | WPRIM | ID: wpr-238285

ABSTRACT

To retain the anti-rheumatoid arthritis activity of melittin and to reduce the hemolysis and hypersusceptibility caused by melittin, a deletion peptide of melittin was synthesized. Its ant-inflammation effect was observed . A hydrophile peptide fragment of melittin was synthesized by standard solid-phase method. The product was analyzed by HPLC and MS. The relevant hemolysis and hypersusceptibility were tested. The rabbits' model of immune arthritis were established and treated. The results showed that the hemolysis rate for peptide fragment was less than 5%, the hypersusceptibility rate was less than 8%. The hydrophile peptide fragment of melittin may retain anti-rheumatoid arthritis activity and reduce the melittin-induced hemolysis and hypersusceptibility.


Subject(s)
Animals , Rabbits , Arthritis, Rheumatoid , Therapeutics , Melitten , Therapeutic Uses , Peptide Fragments , Therapeutic Uses
3.
Journal of Biomedical Engineering ; (6): 135-138, 2003.
Article in Chinese | WPRIM | ID: wpr-311088

ABSTRACT

This paper reviews the development of the polyanhydrides as a new biodegradable polymer, and highlights the methodological and technological progress in the synthesis of the polymer. Subsequently, the future researches and developments of polyanhydrides are prospected.


Subject(s)
Animals , Humans , Rats , Anhydrides , Biocompatible Materials , Brain Neoplasms , Drug Therapy , Delayed-Action Preparations , Diabetes Mellitus , Drug Therapy , Drug Carriers , Drug Delivery Systems , Glioma , Drug Therapy , Osteomyelitis , Drug Therapy , Polymers
SELECTION OF CITATIONS
SEARCH DETAIL